A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison.

Palmer A, Papaluca T, Stoové M, Winter R, Pedrana A, Hellard M, Wilson D, Thompson A, Scott N, EC Victoria Partnership

Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting.

Scott N, Palmer A, Delport D, Abeysuriya R, Stuart R, Kerr CC, Ministry D, Klein D, Sacks-Davis R, Heath K, Hainsworth S, Pedrana A, Stoové M, Wilson D, Hellard ME

COVID-19 Global Infectious Disease Threats Infectious Disease Modelling

Modelling the impact of relaxing COVID-19 control measures during a period of low viral transmission.

Scott N, Palmer A, Delport D, Abeysuriya R, Stuart RM, Kerr CC, Mistry D, Klein DJ, Sacks-Davis R, Heath K, Hainsworth SW, Pedrana A, Stoove M, Wilson D, Hellard ME

COVID-19

Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne, Australia.

Palmer A, Higgs P, Scott N, Agius P, Maher L, Dietze P

Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study.

Palmer A, Scott N, Dietze P, Higgs P

A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment.

Palmer AY, Wade AJ, Draper B, Howell J, Doyle JS, Petrie D, Thompson AJ, Wilson DP, Hellard ME, Scott N